Type 2 Diabetes CD56 NK Cells for Autoimmune and Immunopathology Research

Type 2 Diabetes CD56 NK Cells are cryopreserved from peripheral blood of IRB-consented adult donors diagnosed with Type 2 Diabetes. These CD56+ CD3− natural killer (NK) cells reflect disease-associated immune alterations and offer a critical resource for studying immune surveillance, inflammation, and cytotoxicity in the context of Type 2 Diabetes.

Product Features

• Research Use Only (RUO), CD56+ enriched NK cells
• Isolated from clinically diagnosed Type 2 Diabetes donors
• High viability and enrichment
• Cryopreserved in CryoStore® CS10 media
• Processed within 24 hours of collection
• Ethically sourced with IRB approval and HIPAA compliance

Donor Metadata

• Confirmed diagnosis of Type 2 Diabetes
• Demographics: age, sex assigned at birth, race/ethnicity
• Self-reported clinical history and medication use

Applications

• Investigation of NK cell phenotypes and function in Type 2 Diabetes
• Cytotoxicity, immune exhaustion, and single-cell analysis
• Disease mechanism studies and biomarker identification
• Preclinical immunotherapy development

Compliance and Quality Assurance

• IRB-approved collection and 21 CFR Part 11–compliant e-consent
• Standardized processing and quality protocols
• HIPAA-compliant data handling

Ordering & Customization

Type 2 Diabetes CD56+ NK Cells are offered in standard or custom aliquot sizes. For regulatory documentation or international support, contact [email protected].